Skip to main content
Watch Insiders
KYMRHealthcare

Kymera Therapeutics Inc (KYMR) Insider Trading

In the last 90 days, 2 Kymera Therapeutics Inc (KYMR) insiders reported no open-market purchases and 2 sales totaling $4,158,213. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 1, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 1, 2026Nello MainolfiChief Executive OfficerSale30,000$113.80$3,413,916
Sep 4, 2026Brian AdamsChief Legal OfficerSale6,371$116.83$744,297
Jul 7, 2026Nello MainolfiChief Executive OfficerSale50,000$119.00$5,950,000
Jul 1, 2026Noah GoodmanChief Business OfficerSale3,389$114.29$387,329
Jul 1, 2026Nello MainolfiChief Executive OfficerSale80,000$115.29$9,223,528
Jun 30, 2026Bruce N. JacobsChief Financial OfficerSale77,109$114.96$8,864,828
Jun 29, 2026Bruce BoothDirectorSale31,283$109.48$3,424,800
Jun 29, 2026Bruce BoothDirectorSale513,245$110.01$56,460,132
Jun 26, 2026Biotechnology Value Fund L PCorporate insiderSale1,630,658$106.50$173,665,077
Jun 26, 2026Bvf Partners L P/ilCorporate insiderSale1,630,658$106.50$173,665,077
🔒 Create Free Insider Alerts — Join Watch Insiders

Common questions

KYMR insider trading FAQ

Are KYMR insiders buying or selling?
Over the last 90 days, KYMR insiders were net sellers, reporting $0.00 of open-market purchases and $4,158,213 of sales.
When was the last KYMR insider purchase?
No open-market insider purchase of Kymera Therapeutics Inc stock was reported in the last 90 days.
Where does KYMR insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Kymera Therapeutics Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.